arrow
R

Raveen Rathnasinghe

Icahn School of Medicine at Mount Sinai
H指数:23
被引数:4,413

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Re-engineering segment 8 facilitates generation of a versatile live-attenuated influenza A virus vector platform for secretory protein delivery

改造第8节段促进分泌蛋白递送的多功能减毒甲型流感病毒载体平台的产生

2026-05-190
PRE
MF59-adjuvanted A/Astrakhan influenza vaccine induces cross-neutralizing H5N1 antibodies in ferrets against circulating clade 2.3.4.4b viruses

MF59-adjuvanted A/Astrakhan流感疫苗在雪貂中诱导了针对流行2.3.4.4b亚群病毒的交叉中和抗体。

2026-04-060
OAAI
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
2024-09-160
OAAI
Novel influenza A viruses in pigs with zoonotic potential, Chile

智利具有人畜共患潜力的猪中的新型a型流感病毒

2024-04-022
OAAI
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice

多组分鼻内佐剂用于年轻和老年小鼠的粘膜和持久全身SARS-CoV-2免疫

2023-06-296
OAAI
SARS-CoV-2 Ancestral and Variant of Concern Breakthrough infections boost both cross-reactive cellular and humoral immune responses in mRNA-vaccinated Hamsters.
2023-05-010
OA
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants
MED
IF11.8
2022-10-018
OAAI
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
2022-07-0723
OAAI
Limited extent and consequences of pancreatic SARS-CoV-2 infection
2022-03-0137
OAAI
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
2021-10-2757
OAAI
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
2021-10-2033
OAAI
Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device

使用杀菌紫外线C (UVC) 照射装置对SARS-CoV-2污染的N95呼吸器进行可扩展,有效和快速的去污

2021-10-079
OAAI